A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain.

Trial Profile

A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2009

At a glance

  • Drugs Oxycodone; Paracetamol; Rofecoxib
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 12 May 2009 Trial phase changed from II/III to III as reported by ClinicalTrials.gov.
    • 12 May 2009 Primary endpoints identified as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top